Results 131 to 140 of about 430,496 (159)

2 Treatment with Patiromer Decreases Aldosterone in Patients with Heart Failure, Chronic Kidney Disease, and Hyperkalemia on RAAS Inhibitors

Heart & Lung, 2017
Dahlia Garza, Coleman Gross, Martha Mayo, Jinwei Yuan, Daniel Wilson, Matthew Weir, Bertram Pitt   +6 more
openaire   +1 more source

Dapagliflozin in Patients with Chronic Kidney Disease

New England Journal of Medicine, 2020
Bergur V Stefansson, Ricardo C Correa-Rotter, Glenn Chertow   +2 more
exaly  

Hypoxia-inducible factor–prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease

Kidney International Supplements, 2021
Volker Hans Haase
exaly  

Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes

New England Journal of Medicine, 2020
George Bakris, Rajiv Agarwal, Stefan D Anker   +2 more
exaly  

The next generation of therapeutics for chronic kidney disease

Nature Reviews Drug Discovery, 2016
Matthew D Breyer, Katalin Susztak
exaly  

Empagliflozin in Patients with Chronic Kidney Disease

New England Journal of Medicine, 2023
exaly  

Acute Kidney Injury and Chronic Kidney Disease as Interconnected Syndromes

New England Journal of Medicine, 2014
Lakhmir S Chawla
exaly  

Human medicines European public assessment report (EPAR): Binocrit, epoetin alfa, Anemia,Kidney Failure, Chronic, Date of authorisation: 28/08/2007, Revision: 19, Status: Authorised

Case Medical Research, 2019
openaire   +2 more sources

Genetic and environmental risk factors for chronic kidney disease

Kidney International Supplements, 2017
Matthias Kretzler, Roberto Flavio Pecoits-Filho, Carol Pollock   +2 more
exaly  

Reducing major risk factors for chronic kidney disease

Kidney International Supplements, 2017
Valerie A Luyckx, Katherine R Tuttle, Guillermo Garcia-Garcia   +2 more
exaly